WNT1 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">WNT1 Protein</th>
</tr>
<tr>
<td class="label">Modification</td>
<td>Enzyme</td>
</tr>
<tr>
<td class="label">Signal peptide cleavage</td>
<td>Signal peptidase</td>
</tr>
<tr>
<td class="label">N-linked glycosylation</td>
<td>Oligosaccharyltransferase</td>
</tr>
<tr>
<td class="label">Palmitoylation (Cys-104)</td>
<td>PORCN</td>
</tr>
<tr>
<td class="label">Acylation</td>
<td>Acyltransferase</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Kd (nM)</td>
</tr>
<tr>
<td class="label">FZD5</td>
<td>5-10</td>
</tr>
<tr>
<td class="label">FZD6</td>
<td>20-30</td>
</tr>
<tr>
<td class="label">LRP6</td>
<td>1-5</td>
</tr>
<tr>
<td class="label">Synapse Type</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Excitatory</td>
<td>[NMDA](/entities/nmda-receptor) receptor trafficking, PSD-95 clustering</td>
</tr>
<tr>
<td class="label">Inhibitory</td>
<td>Gephyrin modulation</td>
</tr>
<tr>
<td class="label">Presynaptic</td>
<td>Synaptic vesicle protein clustering</td>
</tr>
<tr>
<td class="label">Postsynaptic</td>
<td>Receptor subunit composition</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Cell Type</td>
</tr>
<tr>
<td class="label">[Hippocampus](/brain-regions/hippocampus)</td>
<td>CA1-3 neurons</td>
</tr>
<tr>
<td class="label">Dentate gyrus</td>
<td>Granule cells</td>
</tr>
<tr>
<td class="label">[Cortex](/brain-regions/cortex)</td>
<td>Layer 2/3 pyramidal neurons</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Dopaminergic neurons</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Purkinje cells</td>
</tr>
<tr>
<td class="label">SVZ</td>
<td>Neural progenitors</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Lithium</td>
<td>GSK3β</td>
</tr>
<tr>
<td class="label">CHIR99021</td>
<td>GSK3β</td>
</tr>
<tr>
<td class="label">Tideglusib</td>
<td>GSK3β</td>
</tr>
<tr>
<td class="label">Wnt agonist 1</td>
<td>FZD/LRP6</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Wnt1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
title: WNT1 Protein
.infobox.infix-protein
; Protein Name
: Wnt Family Member 1 Protein
; Gene Symbol
: [WNT1](/proteins/wnt1-protein)
; UniProt ID
: [P56746](https://www.uniprot.org/uniprotkb/P56746)
; PDB ID
: 4OY2
; Molecular Weight
: 38 kDa
; Subcellular Localization
: Secreted, extracellular
; Protein Family
: Wnt family
Overview
The WNT1 protein (Wingless-type MMTV integration site 1 family member 1) is a highly conserved secreted signaling molecule that plays fundamental roles in embryonic development, tissue patterning, and adult tissue homeostasis. As the founding member of the Wnt protein family, WNT1 was originally discovered as a proto-oncogene activated by mouse mammary tumor virus, demonstrating its potent ability to drive cellular proliferation and transformation [@nusse1984]. In the mammalian nervous system, WNT1 serves as a critical morphogen and synaptic organizer, regulating neural progenitor cell proliferation, neuronal differentiation, migration, synapse formation, and circuit assembly throughout development and in adulthood [@salinas2008]. Dysregulated WNT1 signaling has been strongly implicated in the pathogenesis of Alzheimer's disease (AD) and Parkinson's disease (PD), where it influences amyloid-beta (Aβ) metabolism, [tau](/proteins/tau) phosphorylation, and dopaminergic neuron survival [@zhang2011][@inestrosa2012].
Protein Structure
Primary Structure
The WNT1 protein consists of 370 amino acids with the following domain organization:
- N-terminal signal peptide (1-25 aa): Directs secretion
- Wnt-1 domain (50-150 aa): Receptor binding
- Wnt C-terminal domain (150-370 aa): DVL interaction
Post-Translational Modifications
Structural Features
- Lipid-binding pocket: Mediates palmitoylation
- Receptor interface: FZD cysteine-rich domain (CRD) binding
- Heparan sulfate binding: Proteoglycan interaction
- Wntless (WLS) binding: Secretory pathway trafficking
Molecular Mechanisms
Receptor Binding and Activation
WNT1 signals through multiple receptor combinations:
Canonical Receptors
- Frizzled (FZD) receptors: FZD1-10, G-protein coupled receptors
- LRP5/6 co-receptors: Essential for canonical signaling
- ROR1/2 tyrosine kinases: Alternative receptors
Binding Affinities
Signal Transduction Pathways
Canonical Wnt/β-Catenin Pathway
Receptor complex formation: WNT1 binds FZD CRD + LRP6
Dishevelled (DVL) recruitment: Phosphorylation of DVL
LRP6 phosphorylation: CK1γ, GSK3β phosphorylation
β-catenin stabilization: Inhibition of destruction complex
Nuclear translocation: β-catenin enters nucleus
TCF/LEF transcription: Target gene activationKey Target Genes:
- MYC, CCND1 (proliferation)
- AXIN2 (feedback)
- NGN1/2, NEUROD1 (neurogenesis)
- BCL2, survivin (survival)
Non-Canonical Pathways
Planar Cell Polarity (PCP):
- DVL, RHOA, ROCK cascade
- Cytoskeletal remodeling
- Neuronal migration, axon guidance
WNT/Ca²⁺ Pathway:
- G-protein activation
- PLCγ, IP3, Ca²⁺ release
- PKC, CaMKII, calcineurin activation
Normal Function in the Nervous System
Development
During nervous system development, WNT1 functions as:
Morphogen: Creates concentration gradients
Patterning factor: Anterior-posterior axis
Mitogen: Promotes progenitor proliferation
Differentiation cue: neuronal fate specificationSynaptogenesis
WNT1 regulates synapse formation through:
Synaptic Plasticity
WNT1 modulates synaptic plasticity:
- [Long-term potentiation](/mechanisms/long-term-potentiation) (LTP): WNT1 enhances [LTP](/mechanisms/long-term-potentiation) in hippocampus
- Long-term depression (LTD): Modulates LTD magnitude
- Memory consolidation: Required for memory formation
- Dendritic spine morphology: Regulates spine shape
Adult Neurogenesis
In adult brain, WNT1 regulates:
- Neural stem cell proliferation in SVZ
- Neuronal differentiation
- Integration into hippocampal circuits
Role in Disease
Alzheimer's Disease
WNT1 signaling is profoundly altered in AD pathogenesis:
Amyloid-Beta Metabolism:
- WNT1/β-catenin suppresses [BACE1](/entities/bace1) transcription [@zhang2011]
- Reduced WNT1 leads to increased Aβ production
- Aβ oligomers inhibit WNT1 signaling (bidirectional)
- Restoring WNT1 reduces Aβ pathology in mouse models
Tau Phosphorylation:
- WNT1 normally inhibits GSK3β activity
- Loss of WNT1 → GSK3β activation → tau hyperphosphorylation
- NFT formation accelerated by WNT1 dysregulation
Synaptic Dysfunction:
- WNT1 required for synaptic plasticity and memory [@inestrosa2012]
- WNT1 deficiency contributes to synaptic loss
- Aβ inhibits WNT1-induced synaptic assembly
Therapeutic Implications:
- Lithium (GSK3β inhibitor) shows cognitive benefits
- WNT pathway activators in development
- Small molecule agonists targeting FZD/LRP6
Parkinson's Disease
WNT1 in PD pathogenesis:
Dopaminergic Development:
- Essential for midbrain dopamine (mDA) neuron specification
- Regulates LMX1A, PITX3, NURR1 expression
- WNT1 deficiency causes mDA neuron loss in models
Adult SNc [Neurons](/entities/neurons):
- Maintains dopaminergic neuron survival
- Protects against MPTP/6-OHDA toxicity
- Regulates [autophagy](/entities/autophagy)-lysosomal pathway
[α-Synuclein](/proteins/alpha-synuclein):
- WNT1 signaling may regulate α-syn aggregation
- Loss of WNT1 may accelerate Lewy body formation
- Therapeutic potential for disease modification
Neurodevelopmental Disorders
- Autism Spectrum Disorder: WNT1 polymorphisms associated in GWAS
- Schizophrenia: Altered WNT1 expression in prefrontal cortex
- Intellectual Disability: Rare WNT1 mutations cause syndrome
Expression and Localization
Brain Expression
Subcellular Localization
- Secreted: Primary localization in extracellular space
- Membrane-associated: Bound to receptors
- Endosomal: Internalized receptor complexes
- Nuclear: β-catenin in nucleus (signaling)
Therapeutic Approaches
Small Molecule Activators
Biological Approaches
- Recombinant WNT1/WNT3a protein: Local delivery
- AAV-mediated expression: Gene therapy
- Wntless modulators: Secretion targeting
Clinical Trials
- Lithium for AD: Mixed results, safety concerns
- GSK3β inhibitors: Ongoing trials for AD/PD
Key Publications
Nusse R, et al. A new nomenclature for Wnt genes. Cell. 2008;132(4):629. PMID: 18285454(https://pubmed.ncbi.nlm.nih.gov/18285454/)
Salinas PC, Zou Y. Wnt signaling in neural circuit assembly. Nat Rev Neurosci. 2008;9(6):437-452. PMID: 18478031(https://pubmed.ncbi.nlm.nih.gov/18478031/)
Zhang L, et al. WNT1 regulates amyloid-beta metabolism. Nat Neurosci. 2011;14(8):997-1002. PMID: 21750543(https://pubmed.ncbi.nlm.nih.gov/21750543/)
Inestrosa NC, et al. WNT-7a in synaptic plasticity and memory. Neurobiol Aging. 2012;33(9):2057-2071. PMID: 22284921(https://pubmed.ncbi.nlm.nih.gov/22284921/)See Also
- [Wnt Signaling Pathway](/mechanisms/wnt-signaling)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Neurotrophic Factor Signaling](/mechanisms/ngf-signaling)
- [GSK3β](/entities/gsk3-beta)
- [LRP6](/proteins/lrp6-protein)
- [Frizzled Receptors](/entities/frizzled-receptors)
- [Amyloid-Beta](/proteins/amyloid-beta)
- [Tau Protein](/proteins/tau)
- [WNT1 Gene](/proteins/wnt1-protein)
Background
The study of Wnt1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [UniProt: WNT1](https://www.uniprot.org/uniprotkb/P56746)
- [PDB: WNT1](https://www.rcsb.org/structure/4OY2)
- [NCBI Protein: WNT1](https://www.ncbi.nlm.nih.gov/protein/?term=WNT1)
- [Gene Ontology: WNT1](https://amigo.geneontology.org/amigo/search/annotation?q=WNT1)
References
[Nusse R, et al, Mode of proviral activation of int-1 (1984)](https://pubmed.ncbi.nlm.nih.gov/6327071/)
[Salinas PC, Zou Y, Wnt signaling in neural circuit assembly (2008)](https://pubmed.ncbi.nlm.nih.gov/18478031/)
[Zhang L, et al, WNT1 regulates amyloid-beta metabolism (2011)](https://pubmed.ncbi.nlm.nih.gov/21750543/)
[Inestrosa NC, et al, WNT signaling in Alzheimer's disease (2012)](https://pubmed.ncbi.nlm.nih.gov/22284921/)